New York Blood Center, New York, New York, USA.
Transfusion. 2020 May;60(5):889-891. doi: 10.1111/trf.15771. Epub 2020 Mar 24.
Umbilical cord blood is an important cellular therapy product used for hematopoietic stem cell transplantation, but the US Food and Drug Administration guidance regarding donor screening to reduce the risk of Zika transmission has decreased the number of licensed, eligible cord blood units available for transplantation. There is a crucial need for updated travel risk assessment for Zika virus transmission, validated screening tests for Zika virus in umbilical cord blood, and further research on Zika virus transmissibility due to umbilical cord blood products to ensure that umbilical cord blood and related tissues are safe and available for transplantation.
脐带血是一种重要的细胞治疗产品，用于造血干细胞移植，但美国食品和药物管理局关于减少寨卡病毒传播风险的供者筛查指南，减少了可用于移植的许可合格脐带血单位数量。迫切需要更新寨卡病毒传播的旅行风险评估，验证脐带血中寨卡病毒的筛查检测，以及进一步研究由于脐带血产品导致的寨卡病毒传染性，以确保脐带血和相关组织的安全，并可用于移植。
